Medulloblastoma (MB) is a childhood malignant brain tumour comprising four main subgroups characterized by different genetic alterations and rate of mortality. Among MB subgroups, patients with enhanced levels of the c-MYC oncogene (MBGroup3) have the poorest prognosis. Here we identify a previously unrecognized role of the pro-autophagy factor AMBRA1 in regulating MB. We demonstrate that AMBRA1 expression depends on c-MYC levels and correlates with Group 3 patient poor prognosis; also, knockdown of AMBRA1 reduces MB stem potential, growth and migration of MBGroup3 stem cells. At a molecular level, AMBRA1 mediates these effects by suppressing SOCS3, an inhibitor of STAT3 activation. Importantly, pharmacological inhibition of autophagy profoundly affects both stem and invasion potential of MBGroup3 stem cells, and a combined anti-autophagy and anti-STAT3 approach impacts the MBGroup3 outcome. Taken together, our data support the c-MYC/AMBRA1/STAT3 axis as a strong oncogenic signalling pathway with significance for both patient stratification strategies and targeted treatments of MBGroup3.

Targeting cancer stem cells in medulloblastoma by inhibiting AMBRA1 dual function in autophagy and STAT3 signalling / Nazio, F.; Po, A.; Abballe, L.; Ballabio, C.; Diomedi Camassei, F.; Bordi, M.; Camera, A.; Caruso, S.; Caruana, I.; Pezzullo, M.; Ferraina, C.; Milletti, G.; Gianesello, M.; Reddel, S.; De Luca, C. D.; Ceglie, D.; Marinelli, S.; Campello, S.; Papaleo, E.; Miele, E.; Cacchione, A.; Carai, A.; Vinci, M.; Velardi, E.; De Angelis, B.; Tiberi, L.; Quintarelli, C.; Mastronuzzi, A.; Ferretti, E.; Locatelli, F.; Cecconi, F.. - In: ACTA NEUROPATHOLOGICA. - ISSN 0001-6322. - 142:3(2021), pp. 537-564. [10.1007/s00401-021-02347-7]

Targeting cancer stem cells in medulloblastoma by inhibiting AMBRA1 dual function in autophagy and STAT3 signalling

Ballabio C.;Gianesello M.;Tiberi L.;
2021-01-01

Abstract

Medulloblastoma (MB) is a childhood malignant brain tumour comprising four main subgroups characterized by different genetic alterations and rate of mortality. Among MB subgroups, patients with enhanced levels of the c-MYC oncogene (MBGroup3) have the poorest prognosis. Here we identify a previously unrecognized role of the pro-autophagy factor AMBRA1 in regulating MB. We demonstrate that AMBRA1 expression depends on c-MYC levels and correlates with Group 3 patient poor prognosis; also, knockdown of AMBRA1 reduces MB stem potential, growth and migration of MBGroup3 stem cells. At a molecular level, AMBRA1 mediates these effects by suppressing SOCS3, an inhibitor of STAT3 activation. Importantly, pharmacological inhibition of autophagy profoundly affects both stem and invasion potential of MBGroup3 stem cells, and a combined anti-autophagy and anti-STAT3 approach impacts the MBGroup3 outcome. Taken together, our data support the c-MYC/AMBRA1/STAT3 axis as a strong oncogenic signalling pathway with significance for both patient stratification strategies and targeted treatments of MBGroup3.
2021
3
Nazio, F.; Po, A.; Abballe, L.; Ballabio, C.; Diomedi Camassei, F.; Bordi, M.; Camera, A.; Caruso, S.; Caruana, I.; Pezzullo, M.; Ferraina, C.; Milletti, G.; Gianesello, M.; Reddel, S.; De Luca, C. D.; Ceglie, D.; Marinelli, S.; Campello, S.; Papaleo, E.; Miele, E.; Cacchione, A.; Carai, A.; Vinci, M.; Velardi, E.; De Angelis, B.; Tiberi, L.; Quintarelli, C.; Mastronuzzi, A.; Ferretti, E.; Locatelli, F.; Cecconi, F.
Targeting cancer stem cells in medulloblastoma by inhibiting AMBRA1 dual function in autophagy and STAT3 signalling / Nazio, F.; Po, A.; Abballe, L.; Ballabio, C.; Diomedi Camassei, F.; Bordi, M.; Camera, A.; Caruso, S.; Caruana, I.; Pezzullo, M.; Ferraina, C.; Milletti, G.; Gianesello, M.; Reddel, S.; De Luca, C. D.; Ceglie, D.; Marinelli, S.; Campello, S.; Papaleo, E.; Miele, E.; Cacchione, A.; Carai, A.; Vinci, M.; Velardi, E.; De Angelis, B.; Tiberi, L.; Quintarelli, C.; Mastronuzzi, A.; Ferretti, E.; Locatelli, F.; Cecconi, F.. - In: ACTA NEUROPATHOLOGICA. - ISSN 0001-6322. - 142:3(2021), pp. 537-564. [10.1007/s00401-021-02347-7]
File in questo prodotto:
File Dimensione Formato  
Nazio2021_Article_TargetingCancerStemCellsInMedu.pdf

accesso aperto

Tipologia: Versione editoriale (Publisher’s layout)
Licenza: Creative commons
Dimensione 9.01 MB
Formato Adobe PDF
9.01 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11572/314783
Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 19
  • ???jsp.display-item.citation.isi??? 18
social impact